EYE DROPS FOR NONIONIC SILICONE HYDROGEL CONTACT LENSES

To provide eye drops for nonionic SHCL that can inhibit the adhesion of corneal epithelial cells to a nonionic SHCL surface, particularly, can be applied at the time of wearing a nonionic SHCL, and can inhibit the adhesion of the corneal epithelial cells to the nonionic SHCL surface.SOLUTION: The ey...

Full description

Saved in:
Bibliographic Details
Main Authors FUKUSHIMA KAZUHIRO, NAKADA ATSUKO
Format Patent
LanguageEnglish
Japanese
Published 29.06.2023
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:To provide eye drops for nonionic SHCL that can inhibit the adhesion of corneal epithelial cells to a nonionic SHCL surface, particularly, can be applied at the time of wearing a nonionic SHCL, and can inhibit the adhesion of the corneal epithelial cells to the nonionic SHCL surface.SOLUTION: The eye drops for a nonionic silicone hydrogel contact lens is prepared by using (A) at least one selected from the group consisting of chlorpheniramine and a salt thereof, and (B) menthol together, and by setting the compounding ratio of the component (B) to 0.001 w/v% or more.SELECTED DRAWING: None 【課題】本発明の目的は、非イオン性SHCL表面への角膜上皮細胞の接着を抑制できる非イオン性SHCL用点眼剤、とりわけ、非イオン性SHCLの装用時に点眼可能であって非イオン性SHCL表面への角膜上皮細胞の接着を抑制できる点眼剤を提供することである。【解決手段】(A)クロルフェニラミン及びその塩からなる群より選択される少なくとも１種と(B)メントールとを併用し、且つ該(B)成分の配合割合を０．００１ｗ／ｖ％以上に設定することにより、非イオン性シリコーンハイドロゲルコンタクトレンズ用点眼剤を調製する。【選択図】なし
Bibliography:Application Number: JP20230078010